FatCapitalist:Apple Inc. [AAPL]United States

Know Labs, Inc. [KNWN]United States

Other OTC exchange. Sector: Technology. Industry: Scientific & Technical Instruments. Location United States, Seattle.
At close Thu Sep 15 2022
2.53 USD 👍0.255 (+10.08%)

At close Thu Sep 15 2022

91,003,848 USD


BETA (5y):2.530

for 5 years


for 3 years


for 2 years


for 1 year


for this year

Know Labs, Inc. focuses on the development and commercialization of proprietary technologies in the United States. Its technology uses spectroscopy to direct electromagnetic energy through a substance or material to capture a molecular signature. The company refers to its technology as Bio-RFID. The Bio-RFID technology can be integrated into various wearable, mobile, or bench-top form factors. Its first application of Bio-RFID technology is a product marketed as a glucose monitor that provide the user with real time information on their blood glucose levels. The company was formerly known as Visualant, Incorporated and changed its name to Know Labs, Inc. in May 2018. Know Labs, Inc. was founded in 1998 and is headquartered in Seattle, Washington.

Know Labs is transforming non-invasive medical diagnostics. Bio-RFID™ is Know Labs proprietary non-invasive diagnostic technology platform that uses radio waves to identify and measure what is going on inside your body.

Know Labs, Inc.
© 2022 All rights reserved
Make with 🤎 and ☕ for you!

Investing involves risk, including possible loss of principal.

The strategies discussed are strictly for illustrative and educational purposes and are not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. There is no guarantee that any strategies discussed will be effective.

International investing involves risks, including risks related to foreign currency, limited liquidity, less government regulation and the possibility of substantial volatility due to adverse political, economic or other developments. These risks often are heightened for investments in emerging/ developing markets or in concentrations of single countries.